These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2726980)

  • 1. Systemic and renal hemodynamic response to platelet activating factor.
    Schirmer WJ; Schirmer JM; Galat JA; Fry DE
    Prog Clin Biol Res; 1989; 299():227-32. PubMed ID: 2726980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of atenolol and propranolol on systemic and regional hemodynamics].
    Medvedev OS; Iuzhakov SD; Mashkovskiĭ MD; Val'dman AV; Ismailov ShI
    Biull Eksp Biol Med; 1983 Jul; 96(7):59-61. PubMed ID: 6871455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feline genitourinary and systemic circulatory changes due to a vasopressin hormonogen.
    Greenstein RJ; Dreiling DA
    Mt Sinai J Med; 1984 Jun; 51(3):268-70. PubMed ID: 6611493
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodynamic effects of angiotensin II in conscious, non-ascitic cirrhotic rats.
    Fernández-Muñoz MD; Villamediana LM; Blanchart A; Caramelo C; Hernando L; López-Novoa JM
    Clin Physiol Biochem; 1988; 6(1):36-43. PubMed ID: 3282751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the interactions of acetyl glycerol ether phosphoryl choline with the sympathetic nervous system in rats.
    Sybertz EJ; Sabin C; Baum T; Eynon E; Nelson S; Moran R
    J Pharmacol Exp Ther; 1982 Dec; 223(3):594-8. PubMed ID: 7143227
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
    Hayashi N; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic effect of the combined administration of dobutamine and ATP after hemorrhagic shock].
    Takekawa K; Sakahira K; Sakanishi N; Tsunoda Y; Yokoyama K; Ikezono E
    Masui; 1984 Feb; 33(2):131-6. PubMed ID: 6716647
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic effects of alpha-human atrial natriuretic polypeptide in anesthetized rats].
    Zhao G; Ho SY
    Sheng Li Xue Bao; 1987 Jun; 39(3):310-5. PubMed ID: 2960020
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of platelet activating factor on isolated rat hearts.
    Pugsley MK; Salari H; Beatch GN; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():129-32. PubMed ID: 2274523
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine A directly constricts intrarenal arterioles.
    Abraham JS; Bentley FR; Garrison RN; Cryer HM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):356-9. PubMed ID: 1990551
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine enhances susceptibility to endotoxemic shock in a subset of rats.
    Knuepfer MM; Bloodgood TA; Matuschak GM; Lechner AJ
    Crit Care Med; 2004 Jan; 32(1):175-83. PubMed ID: 14707577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of adenosine di-phosphate (ADP).
    Hoie J
    J Oslo City Hosp; 1973; 23(6):111-8. PubMed ID: 4771836
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of atrial natriuretic hormone.
    Pegram BL; Trippodo NC; Natsume T; Kardon MB; Frohlich ED; Cole FE; MacPhee AA
    Fed Proc; 1986 Aug; 45(9):2382-6. PubMed ID: 2942423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
    Di Francesco GF; Baldoli E; Marchetti G; Glässer A
    Arzneimittelforschung; 1986; 36(1):84-8. PubMed ID: 3954821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the cardiovascular, renal, and coronary effects of dopamine and monensin in endotoxic shock.
    Somani P; Saini RK
    Circ Shock; 1981; 8(4):451-64. PubMed ID: 7023738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of lidocaine on the hemodynamic parameters in rabbits during general anesthesia.
    Orszulak-Michalak D
    Pol J Pharmacol; 1996; 48(2):153-62. PubMed ID: 9112645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion.
    Fukuoka T; Nakajima Y; Horikawa M; Aomatsu Y; Yoshimura A; Ueno M; Ko S; Nakano H
    Transplant Proc; 1993 Apr; 25(2):1809-10. PubMed ID: 8470175
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.